Biopharma industry’s coveted prize recognizes company’s AI-driven precision medicine platform OXFORD, England–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) is honoured to announce that the company has won the Prix Galien USA 2022 Award for Best Digital Health Solution in recognition of its AI-driven precision medicine platform. The award was presented Thursday at the Prix Galien Forum in … [Read more…]
Hanson Brings Extensive Healthcare and Technology Expertise to WBA Board As Company Continues to Accelerate Consumer-Centric Healthcare Strategy DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Bryan C. Hanson to the company’s board of directors. A proven leader with more than 30 years of leadership experience across healthcare, health innovation … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Liver Cancer Treatment Market Research and Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global liver cancer treatment market is anticipated to grow at a CAGR of 10.2% during 2022-2028 The rising prevalence of liver cancer due to poor lifestyles such as consumption of alcohol, diseases such as hepatitis C … [Read more…]
Genmab has Submitted Biologics License Application (BLA) to U.S. Food and Drug Administration (FDA) for epcoritamab European Medicines Agency (EMA) has validated Marketing Authorization Application (MAA) for epcoritamab submitted by AbbVie The submissions are supported by the EPCORE™ NHL-1 open-label, multi-center phase 2 trial evaluating the safety and preliminary efficacy of epcoritamab in adult patients … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Diagnostic Biomarker Market Research and Forecast 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global diagnostic biomarker market is growing at a considerable CAGR of 12.9% during the forecast period. Rising number of research institute focusing on diagnostic biomarkers is one of the prime factors affecting and driving the market. Increasing … [Read more…]
Patients with Extended Treatment Benefit Showed an Objective Response Rate of 77.5% and a Median Duration of Response of 22.1 Months Overall Adverse Event Profile Observed Consistent with Known Safety Profile of Mirvetuximab with Minimal Cumulative Toxicities Study Outcomes in Patients with Long-Term Use Further Support Mirvetuximab’s Potential to Become New Standard of Care for … [Read more…]
NASHVILLE–(BUSINESS WIRE)–Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter … [Read more…]
Healthcare Data Analytics Innovator Also Successfully Completes SOC 2 Type II Assessment NASHVILLE, Tenn.–(BUSINESS WIRE)–#healthcareIT—Ursa Health, a leading provider of data analytics software to the healthcare industry, today announced the Ursa Cloud (residing at Amazon Web Services and Microsoft Azure) and Ursa Hybrid Cloud (residing at Amazon Web Services and Microsoft Azure), in addition to … [Read more…]
MEMPHIS, Tenn.–(BUSINESS WIRE)–$TMX #ESG–Rentokil Terminix, North America’s largest pest control company, today announced a recent donation of $200,000 to St. Jude Children’s Research Hospital®. The donation commemorates the merger of two leading pest control companies, Rentokil and Terminix, to form Rentokil Terminix in North America. The check presentation event, which took place at the Terminix … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Liquid Biopsy Market By Offering, By Technology, Next Generation Sequencing, By Workflow, By Sample, By Circulating Biomarkers, By Application, By End User, By Region Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. The global liquid biopsy market was valued at USD 2,728.57 million in 2021, and during the … [Read more…]
